# Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke

Study · id `cardio:ct-nct01208233` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01208233](<https://clinicaltrials.gov/study/NCT01208233>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01208233

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 181 participants.

## Technical summary

Registry record NCT01208233. Randomized; quadruple masking; primary purpose treatment. Start 2010-12 (registry gives no type); primary completion 2013-12 (actual). Results posted on 2016-02-19.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 181 participants (enrolled count; ClinicalTrials.gov record NCT01208233, source copy `cardio:ctgov-nct01208233-2016-02-19`, retrieved 2026-10-26)
- Start date: 2010-12 (registry gives no type) (ClinicalTrials.gov record NCT01208233, source copy `cardio:ctgov-nct01208233-2016-02-19`, retrieved 2026-10-26)
- Primary completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01208233, source copy `cardio:ctgov-nct01208233-2016-02-19`, retrieved 2026-10-26)
- Completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01208233, source copy `cardio:ctgov-nct01208233-2016-02-19`, retrieved 2026-10-26)
- Results first posted: 2016-02-19 (ClinicalTrials.gov record NCT01208233, source copy `cardio:ctgov-nct01208233-2016-02-19`, retrieved 2026-10-26)
- Countries: United States; Bulgaria; Canada; Czechia; France; Germany; Hungary; India; South Korea; Taiwan (ClinicalTrials.gov record NCT01208233, source copy `cardio:ctgov-nct01208233-2016-02-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01208233-2016-02-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
- Condition: Ischemic Stroke
- Intervention (Drug): PF-03049423
- Intervention (Drug): PF-03049423
- Intervention (Drug): PF-03049423
- Intervention (Other): Placebo
- Lead sponsor: Pfizer
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Pfizer (`cardio:org-pfizer`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Phosphodiesterase-5 Inhibitor PF-03049423 Effect on Stroke Recovery: A Double-Blind, Placebo-Controlled Randomized Clinical Trial (`cardio:pubmed-26738812`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 488b278a832cb47748908321dc7b73b9eff40e58439efae739317062bb3e7a72
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
